As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Cardlytics, Inc. The largest reported stake is CAS Investment Partners, LLC's, at 9.8%. 3 filings are on record since July 16, 2025 (Schedule 13D/A, August 20, 2025).
Sell to companies like Cardlytics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: CAS Investment Partners, LLC · Sole voting: 0 · Shared voting: 5,198,067 · Sole dispositive: 0 · Shared dispositive: 5,198,067 · SCHEDULE 13D/A, 2025-08-20
- · Reporting person: The Vanguard Group · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 2,401,585 · Shared dispositive: 15,324 · SCHEDULE 13G/A, 2025-07-29
- · Reporting person: BlackRock, Inc. · Sole voting: 1,095,873 · Shared voting: 0 · Sole dispositive: 1,098,977 · Shared dispositive: 0 · SCHEDULE 13G/A, 2025-07-16
Cardlytics, Inc. has 3 Schedule 13D or 13G filings on record since 2025-07-16. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001. Each figure below is the holder's own, as filed, with the filing linked.
Layoffs on record: about 90 jobs, latest 2025-10-02 (layoff filings and notices).
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| CAS Investment Partners, LLC | 9.8% | 5,198,067 | SCHEDULE 13D/A, 2025-08-20 | 2025-08-19 |
| The Vanguard Group | 4.6% | 2,416,909 | SCHEDULE 13G/A, 2025-07-29 | 2025-06-30 |
| BlackRock, Inc. | 2.1% | 1,098,977 | SCHEDULE 13G/A, 2025-07-16 | 2025-06-30 |
Holding shares or following this stake? See who's behind Cardlytics, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Cardlytics, Inc. and the records around it.
Cardlytics, Inc. elsewhere on the record
- Leadership changes May 2026
- Layoff notices Oct 2025
- Who owns it
Companies that share a holder
- CAS Investment Partners, LLC also filed stake reports on 1 other company: Hilton Grand Vacations Inc. (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Cardlytics, Inc.
Get an email when Cardlytics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cardlytics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cardlytics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cardlytics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| CAS Investment Partners, LLC | 0 | 5,198,067 | 0 | 5,198,067 | SCHEDULE 13D/A, 2025-08-20 |
| Sosin Master, LP | 0 | 3,198,584 | 0 | 3,198,584 | SCHEDULE 13D/A, 2025-08-20 |
| Cswr Partners, LP | 0 | 1,999,483 | 0 | 1,999,483 | SCHEDULE 13D/A, 2025-08-20 |
| Sosin LLC | 0 | 5,198,067 | 0 | 5,198,067 | SCHEDULE 13D/A, 2025-08-20 |
| Sosin Clifford | 0 | 5,198,067 | 0 | 5,198,067 | SCHEDULE 13D/A, 2025-08-20 |
| The Vanguard Group | 0 | 0 | 2,401,585 | 15,324 | SCHEDULE 13G/A, 2025-07-29 |
| BlackRock, Inc. | 1,095,873 | 0 | 1,098,977 | 0 | SCHEDULE 13G/A, 2025-07-16 |
The latest filing identifies Cardlytics, Inc. by CUSIP 14161W105 and gives its principal executive office as 675 PONCE DE LEON AVENUE, NE, SUITE 4100, ATLANTA, GA 30308 (SCHEDULE 13D/A, 2025-08-20).
Source of funds (Item 3)
Item 3 is hereby amended and restated to read as follows: The Shares purchased by each of Sosin Master and CSWR were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 3,198,584 Shares directly beneficially owned by Sosin Master is approximately $88,620,705, including brokerage commissions.CAS Investment Partners, LLC, SCHEDULE 13D/A, 2025-08-20
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-16 | BlackRock, Inc. | 2.1% | SCHEDULE 13G/A |
| 2025-07-29 | The Vanguard Group | 4.6% | SCHEDULE 13G/A |
| 2025-08-20 | CAS Investment Partners, LLC | 9.8% | SCHEDULE 13D/A |
Questions about who owns Cardlytics, Inc.
Who owns Cardlytics, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Cardlytics, Inc.: CAS Investment Partners, LLC (9.8%, Schedule 13D/A, filed 2025-08-20).
When did CAS Investment Partners, LLC buy into Cardlytics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from CAS Investment Partners, LLC on this page is the Schedule 13D/A, filed 2025-08-20, reporting 9.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Cardlytics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 12, 2026 | Leadership change: Nick Lynton departs, Chief Legal and Privacy Officer | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Cardlytics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.